# US 2014/0371211 A1 · Piroxicam Transdermal Composition to Treat Plantar Fasciitis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0371211 A1
- Document ID: US20140371211A1
- Status: Published application
- Kind: A1
- Application number: 13/917,304
- Filed: 2013-06-13
- Published: 2014-12-18
- Earliest claimed: 2013-06-13
- Assignees: Professional Compounding Centers of America
- Inventors: Andrew B. Glasnapp
- Web page: https://patentgrep.com/patent/US20140371211A1

## CPC

- A61K 31/5415: ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A transdermal composition and method to be used as a treatment for plantar fasciitis is provided. Transdermal composition may include a combination of about 2% w/w to about 5% w/w of piroxicam and about 95% w/w to about 98% w/w of a natural permeation enhancement (NPE) composition. The NPE composition may increase the skin permeability, enhancing the transdermal delivery flux of piroxicam via a single transdermal application, thus, reducing the time of treatment. Transdermal composition may be applied upon an area of treatment, which may include myofascial trigger points linked to pain caused by plantar fasciitis, thus treating this condition more effectively. Moreover, employing a long acting NSAID such as piroxicam, in combination with the NPE composition, may act as a faster and effective treatment for an inflammatory process compared to typical treatments.

## Claims

### Claim 1

A method for treating plantar fasciitis in a patient, comprising administering to the patient an effective amount of piroxicam, in a composition formulated for topical administration and comprising the piroxicam and at least one natural permeation enhancement composition.

### Claim 2 (depends on 1)

The method, according to claim 1, wherein an effective amount of the piroxicam composition administered to the patient is about 5 to 200 mg per day.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the piroxicam composition is administered in multiple doses per day.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the composition comprises about 2% w/w of piroxicam.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the composition comprises about 95% w/w to about 98% w/w of at least one natural permeation enhancement composition.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises one selected from the group comprising a phospholipid, an oil having essential fatty acids, at least one skin lipid, a butter having linoleic acid and linolenic acid, and combinations thereof.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 0.05% w/w to about 5% w/w of one or more phospholipids.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 1% w/w to about 20% w/w of at least one oil having essential fatty acids.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the essential fatty acids are selected from the group consisting of behenic acid, oleic acid, and combinations thereof.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the at least one oil is pracaxi oil.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 0.1% w/w to about 3% w/w of at least one skin lipid.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 1% w/w to about 10% w/w of at least one butter.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the at least one butter comprises one selected from the group consisting of linoleic acid, linolenic acid, and combinations thereof.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises one selected from the group consisting of a hydrogenated phospholipid, an unsaturated phospholipid, pracaxi oil; plukenetia volubilis seed oil, ceramide, squalene, vitellaria paradoxa butter, and combinations thereof.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 10% w/w to about 50% w/w of pracaxi oil.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 15% w/w to about 40% w/w of patauá oil.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 10% w/w to about 30% w/w of inaja oil.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 10% w/w to about 30% w/w of at least one suitable emollient.

### Claim 19 (depends on 1)

The method according to claim 1, wherein the at least one natural permeation enhancement composition comprises about 1% w/w to about 20% w/w of pracaxi oil, about 10% w/w to about 40% w/w of at least one phospholipid, about 5% w/w to about 20% w/w of an oil selected from the group consisting of seje oil, inaja oil, and combinations thereof, and about 5% w/w to about 30% w/w of at least one emulsifier.
